From Phase 2 to Phase 3: how the story developed The Phase 2 NEJM study (Jastreboff 2023) The modern retatrutide story begins with Jastreboff AM et al., published in the New England Journal of Medicine in 2023 (DOI 10.1056/NEJMoa2301972)
These symptoms may indicate a need for dose adjustment, medication support, or temporary pause in titration
We recommend patients seek out and review the prescribing information and medication guides (available online) for any prescription medication to help guide an informed conversation with the prescriber
Thirdly, GLP-1 agonists slow gastric emptying, leading to a delayed absorption of nutrients and a prolonged feeling of fullness, which can contribute to reduced food intake and weight loss
More people are turning to GLP-1 medications to lose weight and manage chronic conditions
Related Reading Glp 1 Medications Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Maximus Glp 1 Pricing and availability current as of June 2026
![Garmin GLO 2 Bluetooth GPS GLONASS Receiver [010-02184-01] Brand_Fireboy-Xintex](https://cdn.shopify.com/s/files/1/0447/7544/0545/files/79966XL.jpg?v=1769649766)
